Sign inJoin waitlistJoin the waitlist

Joe Chang

Professor, Thoracic Radiation Oncology · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Radiation Oncology
Rush University Medical Center
1997–2002
Thoracic Surgery
University of Texas M D Anderson Cancer Center
1990–1993
Fudan University
1988–1990
Doctor of Medicine
1981–1985

Research

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,255 citations
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
The Lancet Oncology · 2015 · First of 25 authors · Corresponding · 1,204 citations
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 922 citations

Zhongxing Liao
100 papers
RK
Ritsuko Komaki
96 papers
James Welsh
65 papers
Daniel Gomez
63 papers
Steven Lin
52 papers · 1 as a resident
JC
James Cox
46 papers
John Heymach
41 papers
Quynh-Nhu Nguyen
31 papers
Matthew Ning
26 papers · 11 as a resident
Michael O'Reilly
26 papers
MJ
Melenda Jeter
25 papers
Jack Roth
23 papers

Clinical trials

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2021–2029
Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART)
Principal investigator · Withdrawn · Phase 1, Phase 2
M.D. Anderson Cancer Center
2019–2024
BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers
Principal investigator · Completed · Phase 1, Phase 2
M.D. Anderson Cancer Center
2019–2025
Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2017–2028